Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group.

Leach JP, Smith PE, Craig J, Bagary M, Cavanagh D, Duncan S, Kelso ARC, Marson AG, McCorry D, Nashef L, Nelson-Piercy C, Northridge R, Sieradzan K, Thangaratinam S, Walker M, Winterbottom J, Reuber M.

Seizure. 2017 Aug;50:67-72. doi: 10.1016/j.seizure.2017.05.004. Epub 2017 Jun 1. Review.

2.

Human herpes virus-6 encephalitis causing severe anterograde amnesia associated with rituximab, azathioprine and prednisolone combination therapy for dermatomyositis.

Baumer T, Fry C, Luppe S, Gunawardena H, Sieradzan K.

J Neurovirol. 2017 Jun;23(3):508-510. doi: 10.1007/s13365-017-0517-0. Epub 2017 Feb 21.

PMID:
28224486
3.

Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.

Peltola J, Holtkamp M, Rocamora R, Ryvlin P, Sieradzan K, Villanueva V.

Epilepsy Behav. 2015 Sep;50:46-9. doi: 10.1016/j.yebeh.2015.05.036. Epub 2015 Jun 24.

PMID:
26114438
4.

Long-term effectiveness and tolerability of vagal nerve stimulation in adults with intractable epilepsy: a retrospective analysis of 100 patients.

Ching J, Khan S, White P, Reed J, Ramnarine D, Sieradzan K, Sandeman D.

Br J Neurosurg. 2013 Apr;27(2):228-34. doi: 10.3109/02688697.2012.732716. Epub 2012 Nov 1.

PMID:
23113878
5.

Late-onset Pompe disease primarily affects quality of life in physical health domains.

Hagemans ML, Janssens AC, Winkel LP, Sieradzan KA, Reuser AJ, Van Doorn PA, Van der Ploeg AT.

Neurology. 2004 Nov 9;63(9):1688-92.

PMID:
15534256
6.

Wound botulism associated with subcutaneous drug use.

Merrison AF, Chidley KE, Dunnett J, Sieradzan KA.

BMJ. 2002 Nov 2;325(7371):1020-1. No abstract available.

7.

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.

Sieradzan KA, Fox SH, Hill M, Dick JP, Crossman AR, Brotchie JM.

Neurology. 2001 Dec 11;57(11):2108-11.

PMID:
11739835
8.

The selective vulnerability of nerve cells in Huntington's disease.

Sieradzan KA, Mann DM.

Neuropathol Appl Neurobiol. 2001 Feb;27(1):1-21. Review.

PMID:
11298997
9.

Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.

Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DM.

Exp Neurol. 1999 Mar;156(1):92-9.

PMID:
10192780
10.

Superior sagittal sinus obstruction and tuberculous abscess.

Barber PA, Sieradzan KS, Schady W.

Acta Neurol Scand. 1999 Mar;99(3):202-3.

PMID:
10100967
11.

Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.

Rascol O, Sieradzan K, Peyro-Saint-Paul H, Thalamas C, Brefel-Courbon C, Senard JM, Ladure P, Montastruc JL, Lees A.

Mov Disord. 1998 Jul;13(4):673-6.

PMID:
9686773
12.

On the pathological progression of Huntington's disease.

Sieradzan KA, Mann DM.

Ann Neurol. 1998 Jul;44(1):148-9. No abstract available.

PMID:
9667607
13.

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.

Colosimo C, Merello M, Hughes AJ, Sieradzan K, Lees AJ.

Neurology. 1998 Feb;50(2):573-4. No abstract available.

PMID:
9484410
15.
16.

The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease.

Sieradzan K, Channon S, Ramponi C, Stern GM, Lees AJ, Youdim MB.

J Clin Psychopharmacol. 1995 Aug;15(4 Suppl 2):51S-59S.

PMID:
7593732
17.

Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Ben-Shlomo Y, Sieradzan K.

Br J Gen Pract. 1995 May;45(394):261-8. Review.

18.

Expression of cholinergic phenotype by embryonic ventral horn neurons transplanted into the spinal cord in the rat.

Clowry GJ, Sieradzan K, Vrbová G.

Restor Neurol Neurosci. 1994 Jan 1;6(3):209-19. doi: 10.3233/RNN-1994-6305.

PMID:
21551751
20.
21.

Possible consequences of disruption of neuromuscular contacts in early development for motoneurone survival.

Greensmith L, Sieradzan K, Vrbová G.

Acta Neurobiol Exp (Wars). 1993;53(1):319-24. Review.

22.

Motor neuron disease model.

Vrbová G, Greensmith L, Sieradzan K.

Nature. 1992 Nov 19;360(6401):216. No abstract available.

PMID:
1296614
23.
24.

Transplants of embryonic motoneurones to adult spinal cord: survival and innervation abilities.

Clowry G, Sieradzan K, Vrbová G.

Trends Neurosci. 1991 Aug;14(8):355-7. Review.

PMID:
1721741
25.

Grafts of embryonic tissue into spinal cord: a possible strategy for treating neuromuscular disorders.

Clowry G, Sieradzan K, Vrbová G.

Neuromuscul Disord. 1991;1(2):87-92. Review.

PMID:
1822786
26.

[The Miller-Fisher syndrome during ECHO-7 neuro-infection. A case history].

Sieradzan K, Kamińska A.

Neurol Neurochir Pol. 1990 Sep-Dec;24(5-6):347-50. Polish.

PMID:
2131433
27.

Replacement of missing motoneurons by embryonic grafts in the rat spinal cord.

Sieradzan K, Vrbová G.

Neuroscience. 1989;31(1):115-30.

PMID:
2771053
28.

Progressive supranuclear palsy with lower motor neuron involvement. A case report.

Sieradzan K, Kwieciński H, Sawicka E.

J Neurol. 1987 May;234(4):247-50.

PMID:
3612195

Supplemental Content

Loading ...
Support Center